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Pseudomonas aeruginosa is a Gram-negative opportunistic human pathogen known to 
cause a variety of infections that are difficult to treat due to extremely high resistance to almost 
all antibiotics currently in clinical use. One of the major contributors to this resistance is the 
active efflux of antibiotics from the cell, primarily by action of the Resistance Nodulation 
Division (RND) family of efflux pumps. These pumps are composed of three proteins; an inner 
membrane RND pump, a periplasmic membrane fusion adaptor protein, and an outer membrane 
protein. The mechanism by which the three proteins interact to form a functional complex is 
largely unknown and the methods currently available for their study involves expression systems 
geared for high levels of expression. In the case of membrane proteins which play a role in 
clinically relevant activities, such as multidrug resistance, an expression system which does not 
always reflect biologically relevant levels of protein in the cell is not ideal for studying their 
interactions as correlation of conclusions from interaction studies to true interactions may not be 
possible. In this study a single copy gene expression system was designed and demonstrated to 
better reflect clinically relevant levels of overexpression compared to a multi-copy expression 
system. Quantitative-real time PCR analysis of C-terminally hexa-histidine tagged 
outermembrane protein, OpmH, expression shows approximately 100-fold and 20-fold 
overexpression from multi-copy and single-copy expression systems respectively. OpmH-H6 was 
successfully purified from both multi copy and single copy expression systems with 
proportionate purification schemes indicating the feasibility of single copy expression systems 
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A PSEUDOMONAS AERUGINOSA: CLINICAL RELEVANCE AND ANTIBIOTIC RESISTANCE 
Pseudomonas aeruginosa is an opportunistic human pathogen that is most well known 
for its ability to infect immune-compromised individuals including Cystic Fibrosis (CF) patients. 
P. aeruginosa colonizes the respiratory tract and is often associated with high rates of mortality. 
(Vettoretti et al. 2009) In the case of critically ill patients, risk factors of nosocomial infection by 
P. aeruginosa include prolonged hospitalization, exposure to antimicrobial therapy and 
possibility of HIV infection (Obritsch et al. 2005). 
It is widely agreed that the reason for the prevalence of this organism in hospitals and 
clinics is due to its intrinsic and acquired multidrug resistance. (Poole and Srikumar, 2001) 
Long-term monitoring and characterization of Gram-negative bacilli present in intensive care 
units across various health centers in the United States found P. aeruginosa to be the most 
frequently isolated organism, and that its multidrug resistance (defined as resistance to three or 
more different classes of antibiotics; in this case extended-spectrum cephalosporins, 
aminoglycosides and a fluoroquinolone) increased more than 5-fold within the 12-year period of 
the study  - more than any of the other isolated organisms (Lockhart et al. 2007). A nation-wide 
study also found P. aeruginosa to be one of the most commonly isolated Gram-negative 
pathogens in Canadian hospitals, and again the only species displaying a multidrug resistant 
phenotype (Zhanel et al. 2008). The development and prevalence of multidrug resistance renders 
treatment options ineffective causing infections by these organisms more dangerous than before. 
Although difficult to track, many groups have reported a positive correlation between multidrug 
resistance in hospital acquired infections of multidrug resistant Gram-negative pathogens, 







i. Mechanisms of antibiotic resistance 
Antibiotic resistance in Gram-negative bacteria, including P. aeruginosa, is the direct 
result of multiple mechanisms operating in parallel including a) low permeability of outer 
membrane b) inactivation of antibiotics by various enzymes; ie. beta-lactamase, aminoglycoside 
modifying enzymes, and tetracycline and macrolide-inactivating enzymes c) alteration of target 
and d) active efflux of compound from the cell (Kumar and Schweizer. 2005). Of the above 
mentioned mechanisms, the most clinically relevant intrinsic antibiotic resistance can be 
attributed to synergism between active drug efflux and reduced drug uptake due to low 
permeability of the outer membrane (Li et al. 1994). Efflux of drugs has been widely studied in 
both Gram-negative and Gram-positive organisms, and has been found to be widespread 
throughout many bacterial species. To date there are five different types of efflux systems: a) 
major facilitator superfamily (MFS) (Pao et al. 1998) b) ATP-binding cassette superfamily 
(ABC) (van Veen and Konings. 1998) c) small multidrug resistance family (SMR) (Chung and 
Saier. 2001) d) Resistance Nodulation Division superfamily (RND) (Nikaido and Zgurskaya. 
2001) and e) Multidrug And Toxic compound Extrusion family (MATE) (Miyame et al. 2001). 
Of these transporters, the RND superfamily is one of the best characterized due to its 
contribution to intrinsic antimicrobial resistance, in Gram-negative bacteria. 
 
B RESISTANCE NODULATION DIVISION PUMPS 
i. Structure 
An RND efflux system spans the entire bacterial cell envelope and are composed of three 






fusion protein (MFP) and an outer membrane protein (OMP) (Zgurskaya and Nikaido. 2000). 
These proteins are genetically encoded in operons where the MFP is encoded first, followed by 
the RND and finally the OMP; a regulator is sometimes encoded in the opposite direction, 
upstream of the MFP. An example of this is the MexAB-OprM RND efflux system of P. 
aeruginosa (Li et al. 1995), where mexA, mexB and oprM are the MFP, RND, and OMP 
respectively; and this system is negatively regulated by a transcriptional repressor mexR, 
encoded upstream of mexA (Srikumar et al. 2000). However, some operons consist of the MFP 
and RND alone, while some OMPs are found to be ‘orphans’, that is, they are not encoded in an 
operon with a cognate MFP and RND. An example of this is the AcrAB-TolC efflux complex of 
E. coli, a close homolog of the MexAB-OprM system, where acrA and acrB are encoded in an 
operon with their local repressor acrR (Ma et al. 1996), while the OMP found to complete the 




Much insight into the pumping mechanism of RND efflux pumps in general; including 
substrate binding, tunnelling, and opening of the channel; has been derived from the crystal 
structures of the AcrAB-TolC complex of E. coli and presumed to function similarly in 
homologous RND pumps in various organisms. The crystal structure of AcrB, revealed the 
homo-trimeric nature of this protein, and that each trimer had a different confirmation differing 













Figure 1 Tri-partite composition of an RND-efflux system. The RND pump (blue), traversing 
the inner membrane is a drug-proton antiporter. The  adaptor-like structure (green) is the 
periplasmic protein that serves to stabilize the interaction between the inner and outer membrane 
structures, known as the Membrane Fusion Protein (MFP). Finally, the channel-like structure 


























tunnel leading from the substrate binding pocket to the opening toward the channel formed by 
the OMP (Murakami et al. 2006). It is thought that each monomer cycles through each 
confirmation and in doing so will bind, channel and efflux a compound (Murakami et al. 2006). 
The crystal structure of Tol C (Koronakis et al. 2000), and OprM (Akama et al. 2004), and OMP 
from P. aeruginosa revealed that this structure was also composed of a homo-trimer, and more 
over the channel it forms is closed at the periplasmic end. Finally, the MFP is classically thought 
to serve as an adaptor, securing the interaction between the other two components of the 
complex, however recent studies indicate a role in opening of OMP channel (Janganan et al. 
2010, Weeks et al. 2010). 
Studies using chimeric RND proteins or heterologous efflux complexes have identified 
importance of the periplasmic loops of the RND transporter in substrate selectivity (Tikhonova et 
al. 2002, Elkins and Nikaido. 2002, Mao et al. 2002). Systematic mutagenesis studies have 
identified residues in AcrB for recognition and binding of substrate (Bohnert et al. 2008) and 
residues in TolC mediating interaction with AcrA (Lobedanz et al. 2007). Gain-of-function 
suppressor studies have identified residues in MexB that are important for mediating interaction 
with MexA (Nehme and Poole. 2005) and OprM (Middlemiss and Poole. 2004, 2007).  
With the body of knowledge available, many models of the steps leading from substrate 
recognition to expulsion have been proposed (Murakami et a. 2006, Fernandez-Reico et al. 2004, 
Pietras et al. 2009), leading to the most recent model proposed by Weeks JW and colleagues, 
(Weeks et al. 2010) which describes a 5-step mechanism by which substrate binding leads to 
opening of the OMP via conformational changes communicated through the MFP. This model, 







iii. Clinical significance 
While AcrAB-TolC and MexAB-OprM of E. coli and P. aeruginosa have served as 
models to understand the mechanism and assembly of these RND efflux complexes, they are 
wide-spread amongst gram-negative organisms. The AdeABC (Magnet et al. 2001), AdeIJK 
(Damier-Piolle et al. 2008) and AdeFGH (Coyne et al. 2010) RND efflux pumps of 
Acinetobacter baumannii have been shown to mediate intrinsic and acquired multidrug 
resistance.  The BpeAB-OprB (Chan et al. 2004), AmrAB-OprA (Moore et al. 1999), BpeEF-
OprC (Kumar et al. 2006), BpeGH-OprD (as well as three other as yet un-characterized RND 
efflux systems of the Gram-negative pathogen Burkholderia pseudomallei were found to be 
expressed in 90% of isolates tested, with 82% of these isolates expressing more than one pump 
(Kumar et al. 2008). Efflux of drugs has been found to play a role in intrinsic multidrug 
resistance of Klebsiella pneumoniae (Aathithan and French. 2011); and some of this activity is 
attributed to the action of AcrAB efflux system (Bialek-Davenet et al. 2011). RND efflux 
systems, while mediating antimicrobial resistance in Vibrio cholerae, was also found to be 
required for production of virulence factors and colonization of infant mice (Bina et al. 2008).  
 
iv. Tools for drug discovery 
Due to their presence in the clinically relevant pathogen and role in multidrug resistance, 
these RND pumps are an attractive option for new therapeutic targets; particularly in the growing 
field of Efflux Pump Inhibitors (EPIs), a compound meant to be used in combination with an 
antibiotic to increase its efficacy (Misra and Bavro. 2009). The complex nature of these tri-






function in binding and extruding an antibiotic. Phe-Arg-β-Napthylamide (PAβN), discovered in 
a screen looking for compounds to poteintiate the activity of levofloxacin in P. aeruginosa 
(Renau et al. 1999) is an example of an EPI that works by competitively binding the substrate-
binding pocket and being effluxed while allowing antibiotic to remain inside the cell and take 
effect on its target. While extremely potent as an EPI, it cannot be used clinically due to toxic 
effects (Olga Lomovskaya, personal communication). It does however provide a foundational 
structure from which to launch more studies into discovery of more effective and potent 
compounds for the use of efflux pump inhibition by way of substrate-binding competition. 
However, as with any system, much more needs to be understood about the way these pumps 
function in order to effectively inhibit their action. 
 
v. Knowledge gaps 
Despite the amount of information available on the structures of each component there 
remain many gaps and unanswered questions as to the in vivo functioning of these tri-partite 
complexes. Although some residues have been identified to mediate the proton relay network in 
AcrB (Takatsuka and Nikaido. 2006, Guan and Nakae. 2001), the sequential protonantion-
deprotonation steps remain unclear, as well as the exact mechanism of drug/proton coupling. 
With respect to the drug transport mechanism a basic understanding of the kinetics of drug 
binding and expulsion and its relation to the energetic involved is lacking. Although the trimeric 
nature of the RND and OMP has been resolved, the stoichiometry with which the MFP fits in 
this complex has yet to be determined. The mechanism by which the components interact and 












Figure 2. Mechanisms to target and inhibit the active efflux pump complex. (adapted from 
Pages and Amaral. 2009) 1. Change regulatory steps taken to express pump, particularly if pump 
has a characterized regulator. 2. Inhibit assembly of fully functional pump in bacterial cell 
envelope. 3. Plug the outer membrane channel to prevent escape of compound into extracellular 
matrix. 4. Breakdown or deplete energy source used for active efflux. 5. Out-compete the 
antibiotic binding sites with a non-antibiotic molecule to inhibit binding and subsequent efflux of 
























relatively uncharacterized with very few studies examining the interactions between native 
complexes.  
 
vi. Suitability of MexJK-OpmH/OprM as model to study functional mechanism 
The MexJK efflux pump was identified by conferring triclosan resistance to a triclosan-
sensitive strain of P. aeruginosa; which was deficient for the two main RND pumps responsible 
for triclosan efflux: MexAB-OprM and MexCD-OprJ (Chuanchuen et al. 2002).
 
The reason this 
efflux complex is of interest is the specificity with which this interaction occurs; MexJK-OpmH 
complex expels triclosan while the MexJK-OprM complex expels erythromycin (Figure 3) 
(Chuanchuen et al 2005) and as seen by the antibiotic susceptibility data presented in this study. 
It is also notable that MexJK-OpmH does not expel erythromycin while MexJK-OprM is not 
capable of effluxing triclosan. The vast difference in chemical structure and size of these two 
antibiotics (Figure 3) indicate a difference in substrate binding and subsequent interaction 
between the components of the complex to efflux the compound.  
Many OMPs are known to interact with multiple RND-MFP complexes. TolC, an OMP 
in E. coli is known to interact with various types of efflux pumps (Koronakis 2003), while OprM 
of P. aeruginosa, is known to interact with MexAB (Gotoh N et al. 1995) and MexXY (Mine et 
al. 1999). The MexJK complex is a novel example of an RND-MFP complex displaying 
promiscuity with respect to OMP partners. This raises the question of whether the two 
complementary complexes, MexJK-OpmH and MexJK-OprM, are formed constitutively but 












Figure 3. Genetic organization of MexJK-OpmH/OprM efflux pump complex. The MexJK 
efflux pump is encoded in the P. aeruginosa as an operon lacking the outer membrane 
component. It has been found to form channels with opmH, which is found elsewhere in the P. 
aeruginosa genome, not near any other RND gene; and with oprM, which is found in another 



























from either OMP and presence of substrate induces the interaction. The selectivity of OMP for 
drug efflux, combined with the unlikely promiscuity displayed by the RND-MFP complex of this 
pump make MexJK-OpmH/OprM a prime model to study the influence of substrate binding on 
tri-partite pump formation.  
As this type of study aims to understand whether an interaction will take place when two 
proteins are expressed in the same cell, it is important that conditions within that cell resemble 
the natural conditions of that cell. In spite of the plethora of genetic, biochemical and bio-
informatic tools available to study these complexes, there remains a gap in the toolbox for 
studying interactions between these proteins at a biologically and clinically relevant level of 
expression. 
 
vii. Tools necessary to address knowledge gaps 
The study of bacterial membrane proteins, including that of RND efflux pumps in P. 
aeruginosa, is commonly carried out by tagging and expressing the recombinant protein from a 
plasmid based system in a host strain engineered for such expression. This system is generally 
geared for high levels of overexpression; ~800-fold increase in transcript levels with the classical 
pBluescriptII KS(-), a commonly used high-copy number cloning vector; (Choi et al. 2008) 
allowing for the purification and subsequent in vitro biochemical characterization of protein of 
interest. While popular due to the straightforward nature of this cloning and expression system, 
there exist a few inherent drawbacks that become significant when considering the study of 






The overexpression of membrane bound proteins has routinely proven to be more 
difficult due to effects on cell viability and low yield of protein (Wagner et al. 2009, Gubellini et 
al. 2011). Despite this, much knowledge has been gained by the expression of membrane 
proteins from medium to high-copy number vectors. Much of the work whereby one of the 
components of the RND efflux complex is mutagenized then assessed for ability to interact with 
cognate or non-cognate partner has been completed in this fashion (Tikhonova et al. 2002, 
Krishnamoorthy et al 2009). While appropriate for determination of ability to interact, this type 
of expression system may not be ideal for the study of native interactions between proteins.  
The levels of overexpression of resistance conferring proteins as detected in clinical 
isolates compared to wild type strains is approximately 2-10-fold as seen in K. pneumoniae 
strains over-expressing acrB in laboratory selected and clinical strains displaying resistance to 
fluoroquinolones and cefoxitin (Bialak-Davenent et al. 2011), as such a plasmid based system 
resulting in much higher levels of expression will not accurately represent biological conditions. 
This consideration is key for studying interactions between protein complexes as correlation of 
conclusions from interaction studies to true interactions may not be possible.  
An appropriate alternative would be to integrate the recombinant protein of interest into 
the chromosome of the host strain allowing for native levels of expression. Such a system was 
described using Tn7 transposition (Choi et al. 2005) whereby the gene of interest is transposed 










Figure 4. Systems for expression of recombinantly tagged proteins resulting in various 
levels of expression. (a) Components of pET expression system. Chromosomally encoded 
lacUV5 promoter and T7 RNA polymerase at the φCTX attachment site and plasmid encoded T7 
promoter and His-tagged protein. LacI is natively transcribed, which will bind the lacUV5 
promoter and repress T7 RNA polymerase expression. Upon addition of IPTG, LacI releases the 
promoter allowing for T7 polymerase expression, which subsequently recognizes the T7 
promoter on the plasmid and transcribe the recombinant protein. It is advantageous that the 
lacUV5 promoter and T7 RNA polymerase are integrated into the chromosome, eliminating the 
need to utilize resources in the maintenance of an extra plasmid. However, the gene of interest 
must be maintained on a high-copy plasmid, thus requiring antibiotic selection in the medium. H6 
– hexa-histidine tag; PT7 – T7 promoter to which T7 RNA polymerase binds and starts 
transcription; ori1600 – origin of replication recognized by P. aeruginosa, bla – B-lactamase gene 
confers resistance to ampicillin (E. coli) and carbenicillin (P. aeruginosa). (b) MiniTn7 
expression system. MiniTn7 vector is incorporated into the att7 site just downstream of glmS 
gene, of which there is only one copy in P. aeruginosa. Transposase A, B, C, and D allow for 
insertion at this location specifically.  Insertion events can be verified by PCR using primers that 
attach to the glmS gene and miniTn7 vector at the Tn7R site. LacI encoded lac repressor binds 
the Ptac promoter until addition of IPTG, whereby the promoter will be released allowing for 
native RNA polymerase to bind and transcribe the recombinant protein. Tn7R and Tn7L: 
attachment sites. FRT: FLP recombinase target sequences; to allow FLP-mediated excision of 
aacC1 gene, encoding gentamycin resistance. MCS: multiple cloning site. Ori: origin of 


















C RESEARCH AIMS 
HYPOTHESIS: 
 Single-copy gene expression system in P. aeruginosa will result in a lower yield of target 
protein, but better approximate biological and clinical levels of expression compared to a multi-
copy gene expression system and therefore allow better means to study protein-protein 
interactions. 
Therefore the objectives of this thesis are: 
 Create two systems for expression of proteins in P. aeruginosa  
 Validate and compare expression of proteins utilizing multi-copy and single-copy 
systems based on mRNA transcript levels, protein expression and phenotypic analysis 
o Multi-copy - pET1.6P vector 































A BACTERIAL STRAINS, GROWTH AND CULTURE CONDITIONS 
 Bacterial strains used in this study is listed in Table 1. Bacteria were routinely cultured in 
Luria-Bertani medium (Biobasic Inc., Markham, ON, Canada) supplemented with appropriate 
antibiotics where necessary to maintain plasmids at the following concentrations: 100 μg/mL 
Ampicillin (Bioshop Canada Inc., Burlington, ON, Canada), 30 μg/mL Gentamycin (Bioshop 
Canada Inc., Burlington, ON, Canada), 200 μg/mL Carbenicillin (Bioshop Canada Inc. 
Burlington, ON, Canada). Counterselection for curing plasmids via the sacB gene was carried 
out in VBMM media (10mM Citric acid, 12mM Sodium citrate, 57mM Potassium phosphate 
dibasic, 17mM Sodium ammonium hydrogen phosphate tetrahydrate, pH 7.0, 0.1mM Calcium 
chloride, and 1mM Magnesium sulfate) supplemented with 10% sucrose (Bioshop Canada Inc., 
Burlington, ON, Canada) and induction of gene expression was accomplished by supplementing 
the growth medium with 0.5mM isopropyl-β-D-thiogalactopyranoside (IPTG) (Biobasic Inc., 
Markham, ON, Canada). Antibiotic susceptibility assays were carried out in Mueller-Hinton 
media (Becton, Dickinson and Company, Sparks, MD, USA). 
 
B DNA MANIPULATIONS 
 Plasmids and oligonucleotides used in this study are listed in Table 2 and Table 3 
respectively. Plasmid DNA was extracted using EZ-10 Spin Column Plasmid Miniprep Kit 
(Biobasic Inc., Markham, ON, Canada) according to manufacturer’s instructions. DNA amplified 
by polymerase chain reaction (PCR) or digested with restriction enzymes were purified by 







Table 1. List of bacterial strains used in this study 
Strain Relevant Characteristics Reference 
E. coli Strains   
DH5α F- φ80d lacZ∆M15 ∆(lacZYA-argF) U169 deoR 
recA1endA1 hsdR17 (rk-, mk+) phoA supE44  λ- thi-1 
gyrA96 relA1  
Laboratory 
collection 
JM109 recA1, endA1, gyrA96, thi,hsdR17(rK-, mK+), 
relA1,supE44, Δ(lac-proAB), [F’,traD36, proAB, 
lacIqZΔM15]  
Promega 
P. aeruginosa Strains 
PAO1 P. aeruginosa prototroph Holloway and 
Zhang 1990 
PAO238-1 PAO1: ∆mexAB-oprM, ∆mexCD-OprJ ↑MexJK Chuanchuen 
et al 2002 
PAO367 PAO238-1: ∆mexXY, ∆opmH Chuanchuen 
et al 2005 
PAO702 PAO367:miniCTX-T7polymerase Kumar lab 
collection 
PA048 PAO702:miniTn7T-Gm-Lac-opmH-H6 This study 
PA049 PAO702:miniTn7T-lac-opmH-H6 This study 
PA050 PAO702:miniTn7T-Gm-Lac This study 


















Table 2. List of plasmids used in this study 
Plasmid Relevant Characteristics Reference 
pCR2.1 Amp
r
  TA cloning vector Invitrogen 
pET21b C-terminal his-tag, T7 polymerase  EMD 
Biosciences 
pET1.6P P. aeruginosa compatible pET21b Choi et al 2008 
pPS1667 pET1.6P-opmH-H6  Choi et al 2008 




 TA cloning vector Promega 
pPLS032 pGEMT-easy-opmH-H6 This study 







 flanked by FRT sites, lacIq
 
multiple cloning site downstream of Ptac  
Choi et al 2005 
pPLS040 miniTn7T-opmH-H6 This study 
pPLS038 miniTn7T-oprM-H6 This study 
miniCTX-T7pol-lacIq Tc
r 





, R6K replicon, helper plasmid encoding site-






, source of Flp recombinase, sacB allows for 
removal of plasmid by sucrose counterselection 























Name Sequence (5’ – 3’) Reference 
Tn7R 72 Tn7R_Fwd CACAGCATAACTGGACTGAT
TTC 
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opmH 142 OpmH_Fwd_RT AGTACCAGAAGGGCGACAAC This Study 
143 OpmH_Rev_RT ATCGGGATGTTCAGTTCCAG This Study 
rpsL 148 RpsL_Fwd_RT GCAACTATCAACCAGCTGGT
G 
Mima et al 
2009  
















Column Gel Extraction kit (Biobasic Inc., Markham, ON, Canada) according to the 
manufacturer’s instructions. Concentration and quality of extracted DNA was measured by 
spectrophotometry using Eppendorf BioPhotometer model AG (Barkhausenweg, Hamburg, 
Germany) and agarose gel electrophoresis respectively. 
 
i. Making chemically competent E. coli DH5α cells 
E. coli DH5α were cultured with a 1/50 inoculum from overnight culture and grown at 
37°C until mid-log phase (OD600 0.4-0.6). Cells were harvested in a pre-chilled rotor at 3800xg, 5 
min at 4°C and re-suspended in 0.4x original culture volume of ice cold Transformation Buffer I 
(TFBI – 100mM rubidium chloride, 50mM manganese chloride, 30mM potassium acetate, 
10mM calcium chloride, 15% w/v glycerol, pH 5.8). Mixture was incubated on ice for exactly 5 
minutes, cells were harvested as before and re-suspended in 0.04x original culture volume of ice 
cold Transformation Buffer II (TFBII – 10mM 3-(N-morpholino) propanesulfonic acid, 10mM 
rubidium chloride, 75mM calcium chloride, 15% w/v glycerol, pH 6.5). Cells were incubated in 
TFBII for 30 min -1 hour then 100 μl aliquots were made and frozen immediately on dry ice and 
stored long-term at -80°C. 
 
ii. Cloning opmH and oprM into pUC18-miniTn7T-Gm-Lac 
Hexa-histidine tagged genes were PCR amplified from previously constructed pET1.6P 
constructs using pET1.6_Fwd_SpeI and pET1.6_Rev_PstI primers (Fig 5a and 5b) with Taq 












Figure 5. Cloning His-tagged OMP into suicide vector miniTn7T. His-tagged genes (a) 
OpmH-H6 (b) OprM-H6 were PCR amplified from respective pET1.6P vectors using primers 
that bind to the vector backbone and contain SpeI and PstI restriction sites on the forward and 
reverse primers respectively. PCR products were gel cleaned and ligated into pGEM-T Easy 
vector and transformed into E. coli JM109 competent cells. After screening for confirmation of 
correct insert by restriction digest, plasmids were cut at indicated restriction sites and ligated to 
appropriately digested pUC18-miniTn7T-Gm-lac vector and transformed into E. coli DH5α 





















instructions. Products were cloned using pGEMT-Easy® vector systems (Promega, Madison, 
WI, USA) according to manufacturer’s protocol. Briefly, purified DNA was ligated into 
linearized pGEM-T Easy vector using T4 DNA Ligase, the reaction was incubated overnight at 
room temperature, the mixture transformed into competent E. coli JM109 cells and plated on LB 
medium containing 100μg/mL ampicillin and 40μg/mL X-Gal. Transformants were screened by 
plasmid extraction and digestion using EcoRI (pPLS032) and PvuII (pPLS037).  
The His-tag containing pGEM-T easy constructs and pUC18-miniTn7T-Gm-LAC were 
digested in a 20μl volume with the restriction enzymes SpeI and PstI (New England Biolabs, 
Pickering, ON, Canada), and appropriate ratios of vector and insert were ligated using T4 DNA 
Ligase (New England Biolabs, Pickering, ON, Canada) and the reaction was incubated overnight 
at room temperature. The ligation mixture was added to an aliquot of competent E. coli DH5α 
cells (created as described above) and incubated on ice for 20-30 min. Cells were heat shocked 
by incubation at 42°C for 90 sec, immediately placed on ice for 2 min and room temperature LB 
broth was added to a total volume of 1mL. The cells were recovered at 37°C with shaking for 1 
hour before plating on LB media containing 100 μg/mL ampicillin. Transformants were screened 
by plasmid extraction and digestion using BamHI and BglII (pPLS038) and AgeI, HindIII and 
BglII (pPLS040). 
 
iii. Delivery of vectors into P. aeruginosa 
All plasmids were delivered into P. aeruginosa strains by electroporation as described 
previously (Choi et al. 2006). Briefly, recipient P. aeruginosa cells were grown overnight and 






 appropriate amount of plasmid DNA was added to the cells and the mixture transferred to a 
2mm electroporation cuvette (Fisher Scientific Canada, Ottawa, ON, Canada). Cells were 
shocked with a 2500V electrical pulse for 5 seconds in the Electroporator 2510 (Eppendorf, 
Westbury, NY, USA), diluted immediately in 1mL of room temperature LB broth and allowed to 
recover for 1 hour at 37°C with shaking before plating on LB agar containing appropriate 
antibiotic.  
1. Multi-copy plasmid-based expression system 
Three millilitres of overnight culture of recipient P. aeruginosa PAO702 cells was 
washed with 300mM sucrose and concentrated to a 100μL volume, to which ~50 - 75ng of either 
pET1.6-opmH-H6 or pET1.6-oprM-H6 plasmid DNA was added. Cells were shocked, allowed to 
recover and plated on LB medium containing 200μg/mL carbenicillin. Transformants were 
verified by plasmid extraction and digestion with AgeI (New England Biolabs, Pickering, ON, 
Canada) for pET1.6P-opmH-H6 and XhoI (New England Biolabs, Pickering, ON, Canada), PstI 
(New England Biolabs, Pickering, ON, Canada) for pET1.6P-oprM-H6.  
2. MiniTn7 based single-copy gene delivery System 
Six millilitres of recipient P. aeruginosa PAO702 overnight culture was electroporated as 
described above with ~600ng of the suicide plasmid pPLS040 and ~200ng of transposase 
encoding vector pTNS2 (Figure 6). Transformants were selected on medium containing 
30μg/mL gentamycin, and insertion of vector into the P. aeruginosa chromosome was verified 
with Tn7R_Fwd and Pa_glmS_Rev primers that bind the vector backbone and P. aeruginosa 













Figure 6. Schematic of creation of single copy system for expression of OpmH-H6. 
MiniTn7T-based vector pPLS040 and site-specific transposase providing vector pTNS2 was 
delivered into P. aeruginosa PAO702 cells. FLP recombinase providing vector pFLP2 was 
delivered into appropriate transformants to remove gentamicin resistance marker, aacC1, 
transformants were screened for sensitivity to gentamicin then cured of pFLP2 plasmid by 
exposure to 10%sucrose. Sucrose tolerant colonies were screened once again for sensitivity to 
gentamicin and carbenicillin (antibiotic resistance marker on pFLP2). Appropriate colonies were 



























marked insertion of opmH-H6 (P. aeruginosa PA048), the gentamycin resistance marker aacC1 
was removed by Flp-FRT system as described previously (Hoang et al. 1998). Briefly, P. 
aeruginosa PA048 was electroporated with 25ng-50ng of Flp-recombinase providing vector 
pFLP2 and transformants were selected on medium containing 200μg/mL carbenicillin and 
screened for sensitivity to gentamicin by patching. The pFLP2 plasmid was then cured by 
exposure to 10% sucrose and screened for sensitivity to carbenicillin. These cells containing the 
unmarked insertion of His-tagged genes were once again verified for presence of the miniTn7T 
vector backbone and the opmH gene using specific primers.  
 
C QUANTITATIVE – REVERSE TRANSCRIPTASE PCR 
i. RNA Extraction 
 RNeasy RNA isolation kit (Qiagen, Mississauga, ON, Canada) was used to extract total 
RNA from cells with or without induction by addition of 0.5mM IPTG according to 
manufacturer’s instructions. Briefly, cells were grown by sub-culturing overnight culture 1:50 
into fresh LB broth, induction of the target gene was achieved by adding 0.5mM IPTG to cells at 
OD600 ~ 0.4-0.6, 1mL of cells were harvested at OD600~0.6 – 0.8 by centrifugation at 17 000xg 
for 3min. Cell pellets were flash frozen at -80°C for 15min – 40min, thawed out at room 
temperature, re-suspended in buffer containing 400μg/mL egg-white lysozyme (Bioshop Canada 
Inc., Burlington, ON, Canada) and disrupted using a guanidine-thiocyanate containing lysis 
buffer. Total RNA was precipitated by adding 96%-100% ethanol and the mix was loaded onto 






RNA was eluted off the column using RNAse-free water, quality and quantity of sample were 
assessed by agarose gel electrophoresis and spectrophotometry respectively. 
 
ii. Complementary-DNA Synthesis 
Genomic DNA was removal was carried out using RNase-free DNAse kit (Qiagen, 
Mississauga, ON, Canada) according to manufacturer’s instructions. Briefly, 2μg of total RNA 
was incubated with 0.5 units of DNase for 30 minutes at 37°C, DNase was inactivated at 65°C 
for 5 minutes and 800ng of RNA was reverse transcribed with GO Script Reverse Transcriptase 
(Promega Corp., Madison, WI, USA). 
 
iii. Real-time PCR 
Real-time PCR was carried out in CFX-96 Thermal Cycler (BioRad Laboratories, 
Hercules, CA, USA Laboratories, Hercules, CA, USA) using Eva green Sso-fast PCR supermix 
(BioRad Laboratories, Hercules, CA, USA). Cycling conditions used were: 95°C 3 minutes; 
95°C 10 seconds, 60°C 30 seconds repeat 39x; while high-resolution melt conditions used were: 
95°C 10 seconds, 65°C – 95°C in 0.5°C increments, 5 seconds/°C. Primers used for detection of 
opmH (110 bp product) and reference gene rpsL (242bp product), were designed using 
OligoPerfect™ Designer program on http://tools.invitrogen.com and are listed in Table 3. 
Efficiency of each primer set was determined by constructing standards using pooled cDNA 
samples. No Reverse Transcriptase (NRT) controls which were included for each cDNA 






also included for each primer set. Expression of target genes under induced and un-induced 
conditions normalized to reference gene was analyzed using the CFX Manager software (BioRad 
Laboratories, Hercules, CA, USA) for gene expression analysis. Raw cycle threshold (CT) 
values for are provided in Appendix A.  
 
D. PURIFICATION OF HIS6X  TAGGED GENES AND IMMUNODETECTION  
i. Culture growth and expression of proteins 
Protein expression, extraction and purifications protocols were followed as described in 
Touze et al. 2004 with some minor changes. For expression of tagged protein from multi-copy 
vector overnight cultures of appropriate strains were sub-cultured 1/100 into a 500mL volume of 
LB supplemented with 200μg/mL carbenicillin and grown at 37°C with shaking at 200 rpm. 
Cultures were induced (0.5mM IPTG) at OD600 0.5 – 0.6 then transferred to 30°C with shaking at 
135 rpm, as this was determined to be optimal for expression of proteins, until OD600 ~ 0.8-1.0. 
P. aeruginosa PAO702 cells harbouring pET1.6P and pET1.6-oprM-H6 were induced only until 
OD600 ~ 0.65-0.7 as these cells would not grow further. Cells were harvested by centrifugation at 
7440xg for 10 minutes at 4°C and cell pellets frozen overnight at -20°C.  
For expression of tagged protein from single-copy expression system cultures were 
prepared in same manner as described above with exception of no antibiotic in medium and 2.5L 
volume. Cultures were induced (0.5mM IPTG) at OD600 ~0.5-0.7 and grown at 37°C with 
shaking at 200 rpm until OD600 1.2-1.5. Cultures were not transferred to lower temperature as no 






early stationary phase as cultures grew readily with no detrimental effects as seen in multi-copy 
system as described above. 
 
ii.  Preparation of Whole Cell Lysate for crude protein expression analysis 
 Whole cell lysates were prepared by two different methods. To analyze proteins from the 
multi-copy system, cells from 1mL of appropriately grown culture (as described above) were 
harvested by centrifugation at 17 000xg for 3 minutes and re-suspended in 2x SDS Sample 
Buffer (SB) (0.2% w/v Bromophenol blue, 20% v/v glycerol, 0.6% v/v β-mercaptoethanol, 4% 
w/v SDS dissolved in a 62.5mM Tris buffer pH 6.8). Volume of sample buffer to dissolve cell 
pellet was determined by the following formula: mL of 2x SB = 0.08xOD600 of culture.  Mixtures 
were boiled for 4 -5 minutes, vortexed and resolved by 10% SDS-PAGE.  
In the case of single-copy expression system, cultures were grown (100mL volume) with 
varying parameters as indicated, cells were harvested by centrifugation at 7440xg, 10min, 4°C 
and cell pellets frozen overnight at -20°C. Pellets were then re-suspended in 4mL of lysis buffer 
(50mM Tris 2mM EDTA), and cells were sonicated on ice using 15:40 pulse: rest cycles until 
cell lysis as determined by visual inspection. Cell debris was removed by centrifugation at 
15300xg for 10min. Samples were denatured by addition of appropriate volume of 2x SB 









iii.  Extraction of membrane proteins 
Cell pellets from cultures grown as described above were thawed at room temperature for 
30 minutes and re-suspended in 1/10 original culture volume of cold lysis buffer (50mM Tris, 
2mM EDTA). The cell suspension was lysed by sonication in Sonic dismembrator model 500 
(Fisher Scientific Canada, Ottawa, ON, Canada). Cell debris was collected by centrifugation at 
15300xg for 10 minutes at 4°C. Membrane fraction was collected by centrifugation at 105 000xg 
in Sorvall® Discovery 100SE (Mandel Scientific Company Inc. Guelph, ON, Canada), for 1 
hour at 4°C. Pellets were solubilized in PUTTS buffer (100mM Sodium phosphate, 8M Urea, 1% 
Triton X-100, 50mM Tris, 1% N-lauroyl sarcosine) and incubated overnight at 4°C with 0.8 - 
1mL of Ni-NTA resin (Pierce Biotechnology, Rockford, IL, USA) equilibrated with 10 – 15 
column volumes of the same buffer.  
 
iv. Purification of tagged protein on Ni-NTA column 
Membrane fractions collected as described above were incubated overnight at 4°C with 
0.8 - 1mL of Ni-NTA resin (Pierce Biotechnology, Rockford, IL, USA) equilibrated with 10 – 15 
column volumes of the same buffer. Resin was washed with 7-10 bed volumes of PUTTS buffer 
containing 10mM imidazole in 500μL fractions. Proteins were eluted in a step-wise manner with 
1mL each of PUTTS buffer containing 200mM, 300mM, 400mM and 500mM imidazole. 
Fractions were collected in a 250μL volume. Fractions of interest were mixed with buffer 
containing β-mercaptoethanol and resolved by sodium-dodecyl-sulfate – 10% polyacrylamide 
gel electrophoresis (SDS-PAGE) run at 50V through the 4% stacking gel (0.5M Tris buffer pH 






0.4% SDS). Proteins were visualized by staining with 0.001% Coomassie Blue R-250 solution 
containing 45% Methanol and 10% glacial acetic acid. Occasionally proteins were visualized by 
staining with silver nitrate. This was carried out by microwaving the gel for 2 minutes with 
shaking every 30 seconds in a prefix solution (50% Methanol, 10% Ethanol), shaking for two 
minutes, replacing the prefix solution with ~100mM Dithiothreitol (DTT) solution, and 
microwaving as before. The DTT solution was replaced with 0.1% silver nitrate, heated for 90 
seconds, and then washed thoroughly with water before adding developer solution (0.05% v/v 
formaldehyde, 3% w/v sodium carbonate. Development was stopped by addition of 2.3M citric 
acid, washed thoroughly with water and stored in a 0.03% sodium carbonate solution. 
 
v. Immunodetection of purified proteins 
Fractions of interest, as determined by SDS-PAGE, were once again resolved by 10% 
SDS-PAGE and transferred onto a nitrocellulose membrane (Thermo Scientific, Mississauga, 
ON, Canada) in a pre-chilled 119mM Tris-4M Glycine-0.1% SDS buffer containing 20% 
Methanol at 4°C, 25V for approximately 16 hours. Membranes were then blocked for ~2h – 3h 
with shaking at 60 rpm, with Phosphate Buffered Saline pH 7.2 containing 0.1% Tween 20 
(PBST) and 10% skim milk, and then washed twice for 10 minutes with 50mL PBST. 
Membranes were then exposed to primary antibody for 1.5 hours with shaking at 60rpm as 
follows: 1:2500 rabbit α-opmH diluted in 10mL PBST + 3% bovine serum albumin (BSA), α-
OpmH (Chuanchuen et al. 2005) was occasionally stored in 25% glycerol, 5μL goat α-OprM (a 
gift from Dr. Herbert Schweizer, Colorado State University, Fort Collins, CO, USA) diluted in 






followed once again by washing twice for 10 minutes with 50mL PBST and exposure to 
secondary antibody for 1 hour with shaking at 60rpm as follows: 2μL of either 2mg/mL 
horseradish peroxidase (HRP)-conjugated Goat α-rabbit (Bioshop Canada Inc. Burlington, ON, 
Canada) or HRP- conjugated mouse α-goat (Thermo Scientific, Rockford, IL, USA) diluted in 
10mL of PBST + 3 % BSA. Membranes were then washed twice for 10 minutes with 50mL 
PBST and developed by addition of 1:10 diluted Pierce ECL detection reagent 1 and 2 (Pierce 
Biotechnology, Rockford, IL, USA) and exposure to CL-Xposure Film (Pierce Biotechnology, 
Rockford, IL, USA) for 2 – 5 minutes. 
 
E.  ANTIBIOTIC SUSCEPTIBILITY TESTING 
i. Agar Dilution Method 
Overnight cultures of appropriate strains were sub-cultured 1:50 into fresh LB, grown to 
OD600 ~ 1 and standardized to 0.5 McFarland in a 0.85% sodium chloride solution according to 
Clinical Laboratory Standards Institute (CLSI) guidelines (Clinical and Laboratory Standards 
Institute 2011). Cells were then diluted 1:50 in Mueller-Hinton Broth (MHB) and a 5μl volume 
was spotted onto Mueller-Hinton Agar (MHA) plates in duplicate. Agar plates were made by 
adding triclosan to a final concentration ranging from 0.5μg/mL – 256μg/mL in serial increments 
of 2. MHA medium was supplemented with 0.5mM IPTG to induce the expression of desired 
proteins. Plates were incubated at 37°C for 18 hours. The MIC was determined to be the lowest 








ii.  Broth Dilution Method 
Bacterial cultures of interest were standardized in the same manner as for Agar Dilution 
Method described above. Antibiotic dilutions were prepared in 96-well plates in triplicate for 
each condition tested (ie. +/- 0.5mM IPTG) whereby two-fold serial dilutions of erythromycin 
(Biobasic Inc. Markham, ON, Canada) were made. Cells were added to the wells, cultures were 
induced where indicated with 0.5mM IPTG at time of plating. Plates were incubated at 37°C for 
18 hours and MIC was determined to be the lowest concentration of erythromycin which 
inhibited bacterial growth. 
 
F. PROTEIN MODELING AND SEQUENCE ALIGNMENT 
 OpmH and OprM were modeled using online modeling program Phyre at 
http://www.sbg.bio.ic.ac.uk/~phyre/. Sequences used for modeling are provided in Appendix C. 
PDB files were downloaded and visualized using the modeling program USCF Chimera version 
1.5.2. Alignment of OpmH to OprM was done using ClustalW2 on the European Bioinformatics 
Institute website at http://www.ebi.ac.uk/Tools/msa/clustalw2/, and was used to identify 






























A CREATION OF EXPRESSION SYSTEMS 
i. Multi copy expression system – pET1.6P vectors  
The multi-copy expression system is comprised of the chromosomally encoded T7 
polymerase and the plasmid encoded His-tagged gene. Expression of this system was confirmed 
by SDS-PAGE and immunoblotting as described in later sections. 
 
ii. Single copy expression system – miniTn7T vectors  
 Construction of the single copy expression system was carried out by inserting the His-
tagged genes into the chromosome of P. aeruginosa PAO702 cells, a process comprised of 
several steps, as described in the Materials and Methods section (Figure 6). Insertion of the 
vector backbone and opmH gene was confirmed by PCR (Figure 7a and 7b).. Expression of this 
system was confirmed by SDS-PAGE and immunoblotting as described in later sections.  
 
B VERIFICATION OF EXPRESSION SYSTEMS  
i. Quantitative-Real Time (Q-RT PCR) analysis of mRNA expression 
 Induction of expression from the multi-copy system resulted in approximately 107-fold 













Figure 7. Verification of P. aeruginosa PA049 by PCR. (a) Insertion of miniTn7 vector and 
(b) Presence of opmH gene. PCR was carried out using primers Tn7R_Fwd and Pa_glmS_Rev 
(listed in Table 3) for confirmation of miniTn7 insertion, yielding a 292bp product. OpmH gene 
was confirmed by PCR using primers OpmH_RT_Fwd and OpmH_RT_Rev (listed in Table 3) 




































Figure 8. Quantitative-Real Time analysis of OpmH-H6 mRNA expression under inducing 
and non-inducing conditions. Complementary DNA was synthesized and analyzed by 
amplification of a 110bp fragment of opmH using 30S ribosomal subunit rpsl as internal control. 
(a) Multi-copy system. Total RNA was extracted from un-induced and induced (0.5mM IPTG) 
mid-log phase P. aeruginosa PAO702/pET1.6P-opmH-H6 cells. Normalized expression analysis 
indicates approximately 107-fold overexpression of opmH mRNA when induced compared to 
un-induced cells. (b) Single-copy system. Total RNA was extracted from un-induced and 
induced (0.5mM IPTG) mid-log phase P. aeruginosa PAO702:miniTn7T-opmH-H6 cells. 
Normalized expression analysis shows a 20-fold overexpression under inducing conditions 

























single-copy system resulted in approximately 20-fold overexpression of opmH-H6 mRNA 
compared to un-induced cells (Figure 8b).  
 
ii. Protein expression analysis of whole cell extracts 
 Upon induction of target protein from multi-copy vector pET1.6P, a prominent band 
weighing approximately 50kDA, the approximate weight of both outer membrane proteins 
OpmH and OprM, was observed (Figure 9a and 9b). Induction of the single-copy expression 
system did not yield a visibly detectable over-expressed protein in the range of the expected 
molecular weight by this method (Figure 9c). When these cell lysates were probed with 
polyclonal rabbit α-OpmH, no signal corresponding to OpmH was detected (Fig 9d). The bands 
that are observed in the whole cell extracts are expected to be non-specific targets that cross-
react with the α-OpmH, no cross-reaction was observed with the secondary goat- α-rabbit (Data 
not shown).  
 
C.  ANTIBIOTIC SUSCEPTIBILITY ANALYSIS OF PHENOTYPE 
Phenotypic verification of constructs was analyzed by antibiotic susceptibility assays 
where the MIC was determined for each strain by agar dilution (Triclosan) or broth dilution 
(Erythromycin) method according to CLSI guidelines. As the MexJK-OpmH complex has been 
shown to efflux triclosan, resistance to this biocide was used as indication of functional complex 
formation. Alternatively, resistance to erythromycin was used as evidence of functional MexJK-






Figure 9. Protein expression analysis by whole cell extracts. (a) OpmH-H6 expression from 
multi-copy system. Lane M-molecular weight marker, lane 2-Whole Cell Lysate (WCL) from P. 
aeruginosa PAO702/pET1.6 + 0.5mM IPTG, lane 3-WCL from P. aeruginosa PAO702/pET1.6-
opmH-H6 + 0.5mM IPTG. SDS-PAGE analysis of P. aeruginosa PAO702 cells harbouring 
pET1.6 or pET1.6-opmH-H6 were grown at 37°C until mid-log phase, induced (0.5mM IPTG) 
and grown for 2 hours at 30°C. (b) OprM-H6 expression from multi-copy system. Lane M-
molecular weight marker, lane 2-WCL from P. aeruginosa PAO702 cells without any plasmids, 
lane 3-WCL from P. aeruginosa PAO702/pET1.6 + 0.5mM IPTG, lane 4-WCL from un-induced 
P. aeruginosa PAO702/pET1.6-oprM-H6, lane 5-WCL from P. aeruginosa PAO702/pET1.6-
oprM-H6 + 0.5mM IPTG. SDS-PAGE analysis of P. aeruginosa PAO702 cells harbouring 
pET1.6 and pET1.6-oprM-H6 were grown at 37°C, and induced with 0.5mM IPTG and grown at 
30°C and until mid-log phase. P. aeruginosa PAO702 cells without any plasmids were grown at 
37°C and harvested at OD600 1.1. (c) OpmH-H6 expression from single-copy system, P. 
aeruginosa PA049. Lane M-molecular weight marker, lane 2-WCL from un-induced cells, lane 
3-WCL from cells induced (0.5mM IPTG) at time of inoculum and grown at 37°C, lane 4-WCL 
from cells induced (0.5mM IPTG) at time of inoculums and grown at 30°C, lane 5-WCL from 
cells induced (0.5mM IPTG) at mid-log phase and grown at 37°C, lane 6-purified OpmH-H6 
from multi-copy vector. P. aeruginosa PAO702:miniTn7T-opmH-H6 cells grown in 100mL LB 
broth were harvested and whole cell lysate prepared as described in Materials and Methods. Cell 
lysates were analysed by reducing 10% SDS-PAGE. Purified OpmH-H6 from multi copy was 
included as positive control for comparison purpose. Western detection of OpmH-H6 (d) (same 




























Table 4. Antibiotic susceptibility profile of P. aeruginosa PAO702 constructs. Minimum 
inhibitory concentrations for Triclosan, a substrate for the MexJK-OpmH efflux complex, were 
determined according to CLSI standards and as described in Materials and Methods. MIC 
reflects the lowest concentration of antibiotic or compound to inhibit growth of bacteria. (a) 
Triclosan. Agar dilution method was used to determine triclosan MIC. (b) Erythromycin. Broth 
dilution method was used to determine erythromycin MIC. Data shown is representative of at 

























Fold change in 
MIC compared to 
PAO702 
-IPTG +IPTG -IPTG +IPTG 
PAO702 MexJ, MexK 0 4 4 0 0 





Multiple 256 4 64 0 

















Fold change in 
MIC compared to 
PAO702 
-IPTG +IPTG -IPTG +IPTG 
PAO702 MexJ, MexK 0 31.25 31.25 0 0 










Multiple 62.5 31.25 2 0 








P. aeruginosa PAO702/pET1.6P-opmH-H6 cells displayed a high level of resistance 
under non inducing conditions with 64-fold change in MIC compared to parental strain P. 
aeruginosa PAO702 (Table 4). However, induction of pET1.6P-opmH-H6 caused a significant 
decrease in resistance with MIC comparable to that of the parental strain. This high-level of 
resistance was not observed in P. aeruginosa PAO702/pET1.6P-oprM-H6 cells (appendix B), 
indicating that the increase in resistance observed is due to presence of opmH gene specifically.  
In contrast, P. aeruginosa PA049 cells displayed high-level of resistance upon induction 
with a 32-fold change in MIC compared to the parental strain (Table 4). Although an increase in 
resistance is observed upon induction of empty vector, it is only two-fold, an insignificant 
change as outlined by the CLSI standards (Clinical Laboratory Standards Institute, 2011).  
P. aeruginosa PAO702/pET1.6P-oprM-H6 displays a high level of resistance to 
erythromycin under non-inducing conditions compared to strain containing empty vector and 
parental strain (Table 4). This is consistent with the trends observed with P. aeruginosa 
PAO702/pET1.6P-opmH-H6 and triclosan susceptibility levels. 
 The PAO702/pET1.6-opmH-H6 colonies on the MHA + IPTG plates were considerably 
smaller than their growth on the uninduced MHA plates (Figure 10a), indicative of the effect of 
IPTG on the cell’s fitness and viability. This same effect was not observed for the colonies of 















Figure 10. Colony morphology of strains expressing OpmH-H6 from multi- and single-
copy. P. aeruginosa (a) PAO702/pET1.6-opmH-H6 and (b) PA051 colonies were grown, 
standardized and diluted as described in Materials and Methods for Agar Dilution MIC. Two 
representative plates of colony morphology under inducing (indicated) and non-inducing 






















D. PROTEIN PURIFICATION AND DETECTION 
i. Purification of tagged proteins from multi-copy expression system  
The first three elution fractions from P. aeruginosa PAO702/pET1.6P-opmH-H6 cells 
induced to express OpmH-H6 contained a strong band weighing approximately 50kDa, as seen in 
the protein expression studies (Figure 11a indicated by arrow). A similar observation was made 
for P. aeruginosa PAO702/pET1.6P-oprM-H6 cells (Figure 11b indicated by arrow). Absence of 
this band from P. aeruginosa PAO702/pET1.6 cells subjected to the same purification scheme 
(Figure 11c), indicates 50kDa band to be the respective purified His-tagged protein. 
Purification of protein of interest was further confirmed by probing the fractions of 
interest with antibodies raised against OpmH or OprM. The prominent 50kDa bands present in 
the fractions from cells containing pET1.6P-opmH-H6 were detected by the α-opmH antibodies 
while no signal was detected in the fractions originating from cells harbouring the empty 
pET1.6P vector (Figure 11d top panel). Similarly, the prominent 50 kDa bands present in the 
fractions from cells containing pET1.6P-oprM-H6 were detected by the α-OprM (Figure 11d 
bottom panel) antibodies while no signal was detected in the fractions originating from the empty 
vector. There was also no cross reaction between purified OpmH-H6 and α-OprM antibodies or 
vice versa, indicating that while the α-OpmH has cross-reacting material within the whole cell 
lysate, it does not detect OprM (Fig11d). 
 
ii. Purification of OpmH-H6 from single-copy expression system 
The first three elution fractions from P. aeruginosa PAO702:miniTn7T-opmH-H6 cells induced 







Figure 11. Purification of His-tagged proteins expressed from multi-copy system on by 
affinity chromatography. (a) OpmH-H6 from P. aeruginosa PAO702/pET1.6-opmH-H6. 
Lane M-molecular weight marker, lane 2-cell debris, lane 3-supernatant from ultracentrifugation 




 elution fractions. (b) OprM-H6 
from P. aeruginosa PAO702/pET1.6-oprM-H6. Lane M-molecular weight marker, lane 2-flow 
through, lane 3-1
st
 wash fraction, lane 4-6
th
 wash fraction, lane 5-10
th





 elution fractions (c) Purification from P. aeruginosa PAO702/pET1.6. Lane M-
molecular weight marker, lane 2-material loaded onto column, lane 3-flow through, lane 4-1
st
 
wash fraction, lane 5-7
th





 elution fractions. The column was washed with 8-10 bed volumes of PUTTS buffer 
containing 10mM imidazole, and eluted with 1mL each of PUTTS buffer containing 200mM – 
500mM imidazole, increasing in 100mM increments. Fractions were resolved by 10% SDS-
PAGE stained with Coommassie blue R-250. (d) Detection of purified His-tagged proteins 
with respective antibodies. First elution fraction from each purification as well as membrane 
proteins from P. aeruginosa PAO750, a strain deficient for both OprM and OpmH was resolved 
by SDS-PAGE, transferred onto a nitrocellulose membrane and probed with polyclonal rabbit-α-
OpmH antibodies or goat-α-OprM antibodies. Lane M-molecular weight marker, lane 2-first 
eluate from P. aeruginosa PAO702/pET1.6-oprM-H6, lane 3-first eluate from P. aeruginosa 
PAO702/pET1.6, lane 4-first eluate from P. aeruginosa PAO702/pET1.6-opmH-H6, lane 5-










































seen with purification from the multi-copy vector (Figure 12a). Upon closer inspection however, 
one of the fractions did contain a band of same molecular weight as that purified from multi-
copy. The first three elution fractions along with purified OpmH-H6 from multi copy system 
were subjected to SDS-PAGE stained with the more sensitive silver nitrate, which has a limit of 
detection of ~0.1ng protein/band (Dunn and Crisp, 1994) thus allowing for a better picture of the 
proteins present within these samples (Figure 12b). The third elution fraction contained a faint 
band which lined up with the prominent one in the lane containing purified OpmH-H6 sample 
(Figure 12b, indicated by arrow). Immunodetection using α-OpmH antibody, confirmed the band 


















Figure 12. Purification of OpmH-H6 from single copy expression system. (a) Coommassie 
stain of OpmH-H6 purification fractions. Lane M-molecular weight ladder, lane 1-column 
flow through, lane 2-1
st
 wash fraction, lane 3-7
th
 wash fraction, lane 4-10
th
 wash fraction, lane 5-




 elution fractions. P. aeruginosa PAO702:miniTn7T-opmH-H6 cells were grown in a 
total of 2.5L volume at 37°C induced (0.5mM IPTG) at mid-log phase and grown further at 37°C 
until early stationary phase, at which time they were harvested. Cell lysis, isolation of membrane 
fraction, purification of OpmH-H6 and analysis of fractions was carried out as described above. 
(b)Silver nitrate stain of OpmH-H6 purification fractions. Lane 1-purified OpmH-H6 from 




 elution fractions. Fractions of interest were analyzed by 
staining with silver nitrate (as described in materials and methods section). (c) immunodetection 





 elution fractions, lane 5-membrane proteins from P. aeruginosa PAO750. Fractions 
of interest were transferred onto a nitrocellulose membrane and probed with polyclonal rabbit α-
opmH. OpmH-H6 purified from multi-copy system was used as positive control and membrane 






































A MULTI-COPY EXPRESSION SYSTEM 
 i. Protein expression and purification 
 The prevalence of RND efflux pumps and their ability to expel a wide range of substrates 
including antibiotics confers intrinsic and acquired multidrug resistance to important pathogens 
such as E. coli, P. aeruginosa, K. pneumoniae and A. baumannii, rendering antibiotic treatments 
ineffective. This makes these protein complexes an appealing target for discovery of new drugs 
and the focus of much research aimed at understanding the various aspects of the proper 
functioning of RND efflux pumps. Crystal structures of the individual components have 
provided insight as to the pumping mechanism of the RND transporter. Genetic and biochemical 
studies have allowed the characterization of the regions and specific residues that mediate 
interaction between components, binding of substrate and transduction of energy necessary to 
expel drug. Nevertheless, a basic understanding of the mechanism of functional assembly of the 
tri-partite complex is still lacking. One approach to elucidating these mechanisms is the study of 
native interactions between the components of the RND pump complex, however the membrane 
bound nature of these proteins makes this type of characterization more challenging. 
The array of techniques used to examine the interactions between membrane proteins 
begin with cloning the gene of interest into a high-copy number plasmid to allow high enough 
levels of protein production for subsequent purification and characterization. This has proven 
successful in much of the characterization of RND efflux pump complexes. Vectors pSPORTI 
(Takatsuka and Nikaido. 2006), pUC18 (Tikhonova and Zgurskaya. 2004), pTrc99a (Hussain et 
al. 2004) and various derivatives are commonly used to express the various efflux components to 






A P. aeruginosa compatible derivative of the pET vector was used to examine multi-
copy, plasmid-based expression systems in this study and it is clear that with minimal 
optimization purification of protein under these conditions is readily attainable, as seen 
previously (Mokhonov et al. 2004). Although not quantified, it is easy to see by 10% SDS-
PAGE with coommassie staining that upon induction, tagged protein is produced by the cell in 
very high quantities such that it is detectable in whole cell lysate from 1mL of culture (Figure 9a 
and 9b) and only a small amount of culture is required for their purification, 0.5 L in this study 
(Figure 10a and 10b). Furthermore, as the amount of target protein produced inside the cell is so 
high, purification schemes become forgiving to loss of yield during the various steps. For 
example, the cell lysis step in the purification of OpmH-H6 from P. aeruginosa PAO702/pET1.6-
opmH-H6 resulted in some loss of target protein seen by the presence of a thick 50kDa band in 
the cell debris (Figure 10a), and loss of protein in column flow through as seen in the flow 
through while purifying OprM-H6 from P. aeruginosa PAO702/pET1.6-oprM-H6 (Figure 10b). 
For these reasons multi-copy vectors are the choice method for purifying these proteins. 
However, to study and elucidate native interactions between proteins, a purification 
scheme utilizing native protein must be devised, or a recombinant system for purification of 
protein that mimics native conditions must be developed. Analysis of mRNA transcript levels of 
a His-tagged OMP from P. aeruginosa, opmH-H6 shows a 107-fold increase in expression upon 
induction from a pET-based vector made compatible for expression in this bacterium (Figure 8a). 
This is not consistent with what is observed in either laboratory-derived mutants or clinical 
isolates displaying a multidrug resistant phenotype attributed to up-regulation of efflux pump 
expression. K. pneumoniae mutants isolated in laboratory settings displaying resistance to 






by only 2-10-fold (Bialek-Davenet et al. 2011). Components of RND efflux pumps were found 
to be expressed ~2-5-fold more in multidrug resistant clinical isolates of A. baumannii compared 
to a susceptible reference strain (Coyne et al. 2010), and ~2-39-fold in multidrug resistant 
clinical isolates of P. aeruginosa compared to wild-type laboratory strain P. aeruginosa PAO1 
(Hocquet et al. 2006). As the ultimate goal of studying RND efflux pumps is to eventually 
inhibit their action in clinical settings, it is necessary to adapt an expression system that better 
approximates the levels of expression observed in clinical isolates.  
 
 ii. Phenotypic analysis 
While an abundance of target protein was observed upon induction of multi-copy 
expression system, a severe decrease in resistance and overall cell-viability is also observed 
under these conditions. When induced P. aeruginosa PAO702 cells harbouring either pET1.6-
opmH-H6 or pET1.6-oprM-H6 display a severe drop in triclosan (Table 4a) and erythromycin 
(Table 4b) MIC respectively. The P. aeruginosa PAO702/pET1.6-opmH-H6+IPTG colonies 
observed on triclosan containing MHA plates were significantly smaller and seemingly less fit 
than their un-induced counterparts (Figure 10). This observation raises the question of whether 
the vast amount of protein produced upon induction is functional in its efflux capabilities.  
Particles resembling aggregates, similar to that observed by Wagner S. and associates 
during the over-expression of GST fusions of membrane proteins YidC, YedZ and LepI in E. 
coli (Wagner et al. 2007) were observed during the purification of OprM-H6 after the culture had 
been induced It is of note that these aggregates were reported to contain the overexpressed 






proteins; and were not observed when the soluble GST-GFP fusion was over expressed (Wagner 
et al. 2007). This may provide some insight as to the fate of the excess protein produced upon 
induction, indicating that the cell does not use these proteins for efflux purposes. The hyper-
sensitivity to substrate and low fitness of culture upon induction illustrates the toxicity associated 
with over-expression of membrane proteins and the need for a system of protein expression that 
upon induction can achieve conditions that better reflect biological conditions. 
  
B SINGLE-COPY EXPRESSION SYSTEM 
i. Protein expression and purification 
 A system that stably incorporates and expresses the target gene from the bacterial 
chromosome in single-copy has the potential to more accurately mimic biologically relevant 
conditions. Such a system was described by Choi and associates (Choi et al. 2005) utilizing the 
bacterial transposon Tn7 and its well characterized transposition into the bacterial chromosome 
at the Tn7 attachment site (attTn7). The strengths of this expression system lies in the predictable 
and well characterized Tn7 transposition mechanism (Choi et al. 2005). This transposon, while 
capable of high-frequency non-specific transposition into conjugal plasmids using the 
TnsABC+E proteins, it is also capable of specific and polar insertion into the bacterial 
chromosome at the attTn7 site located downstream of the glmS gene encoding a highly 
conserved bacterial glutamine synthetase (Peters and Craig. 2001). The specificity of the second 
mode of transposition is directed by the sequence specific DNA binding protein, TnsD of the 
Tn7 transposition system. The specificity, polarity and high frequency of insertion into the 






expression system whereby any gene of interest can be cloned and expressed in a wide variety of 
bacterial hosts (Choi et al. 2005).  
This single-copy gene expression system was successfully shown to replicate up-
regulation of RND efflux pumps to the same levels as that of a mutant promoter (Mima et al. 
2007). The TriABC-OpmH RND efflux pump of P. aeruginosa was discovered by screening 
triclosan-sensitive mutants for increased resistance to this biocide (Mima et al. 2007). The 
resistance was attributed to a promoter-up mutation in the promoter of the TriABC pump which 
resulted in a >7-fold increase in MIC and ~10-fold increase of this pump compared to the 
triclosan-sensitive strain. Upon cloning this pump into the single-copy gene expression vector, a 
>8-fold increase in MIC compared to strain not expressing the pump and ~9-fold increase in 
TriABC pump expression compared to triclosan-sensitive strain was achieved. 
 In this study, the single-copy system was adapted for the expression of the efflux 
component opmH-H6. Induction of the system results in a 20-fold increase in expression of target 
mRNA transcript compared to un-induced cells (Figure 8b), which as seen previously (Mima et 
al. 2007) is a more accurate replication of biological systems than a multi-copy system.  
While such a system is more appropriate for the study of native interactions between 
efflux complex components, it is less favoured due to the lowered levels of expression making 
purification of target protein proportionately more troublesome. The classic obstacles faced when 
purifying membrane proteins surface when implementing this system of expression. Culture 
volume, induction conditions, cell lysis and affinity purification are some parameters that may be 
standardized to determine the optimal conditions for the purification of target protein. As 






as was attained with multi-copy expression system. In the case of P. aeruginosa PA049, a larger 
culture volume (2.5L), and longer induction was required to purify OpmH-H6. Elution fractions 
from the purification scheme had to be subjected to the more sensitive stain silver nitrate to 
visualize the faint band corresponding to putatively purified OpmH-H6 (Figure 11b), which was 
finally detected by immunoblotting (Figure 11c). Taken together, these studies show that while 
multi copy expression systems drive strong protein expression, allowing for straightforward 
purification of target protein in high yields; expression and purification from single-copy 
expression systems is both achievable and detectable. 
 
ii. Phenotypic analysis 
Despite the low levels of protein production upon induction of the single-copy expression 
system, antibiotic susceptibility data also indicates that this system is more reflective of a clinical 
strain (Coyne et al. 2010, Sobel et al. 2005) than the multi-copy system as a 32-fold increase in 
triclosan MIC upon induction of opmH-H6 compared to strains not expressing the OMP (Table 
4a). This phenotype is indicative of an interaction of the induced OpmH-H6 with MexJK to form 
a functional efflux complex capable of triclosan efflux. This data is comparable to the previously 
published report (Chuanchuen et al. 2002) where the MexJK pump was discovered to efflux 
triclosan due to a promoter-up mutation; in the absence of MexAB-OprM and MexCD-OprJ. The 
mutant strain capable of effluxing triclosan had an MIC for this compound of 128μg/mL whereas 
the parental strain had a triclosan MIC of 20μg/mL. Thus the single-copy expression system 
successfully replicates a biological system, while allowing for further study of this system as the 






























A PURIFICATION OF OPRM-H6 FROM SINGLE COPY EXPRESSION SYSTEM 
 While OpmH-H6 has been successfully purified and detected from the single-copy 
expression system, OprM-H6 has yet to be inserted into P. aeruginosa PAO702 in single copy. 
Once this construct has been made, characterization of its expression by q-RT PCR and 
antibiotic susceptibility assays will have to be completed. Although both are outer membrane 
proteins, conditions used to purify OpmH-H6 may not translate directly to the purification of 
OprM-H6, but nevertheless the purification scheme outlined in this study is an acceptable place 
to start.  
 
B CO-PURIFICATION STUDIES OF MEXJK-OPRM/OPMH EFFLUX COMPLEX 
 The applications of a single-copy gene expression system transferrable to any bacterial 
species containing att7 sites are numerous. One such application utilizing the constructs made in 
this study is the investigation of the interactions between the RND-MFP complex MexJK and the 
two outer membrane proteins it is known to interact with, OpmH and OprM.  
Pull down studies where by the OMP is purified and fractions of interest are probed for 
presence of MFP or RND under various conditions, whereby substrate is present and/or absent 
will give further insight about the nature of this interaction. For this reason, the single-copy gene 








C MODELLING AND SITE-DIRECTED MUTAGENESIS STUDIES OF OPRM AND OPMH 
 The substrate specificity with which the MexJK pump interacts with the OMPs OprM 
and OpmH can be exploited to better understand the interaction between the RND-MFP complex 
and the OMP. In particular site-directed mutagenesis of residues in the OMP known to mediate 
interaction with the MFP to elucidate whether the substrate specificity can be reversed. Previous 
mutagenesis studies in the OprM homolog TolC have shown helices 3 and 8 of the OMP to 
mediate interaction with its MFP, AcrA (Lobedanz et al. 2007). Further mutagenesis and 
suppressor studies in MexAB-OprM of P. aeruginosa identified residues T198 and F439 in 
OprM to suppress the hypersensitive phenotype of a mutation in the MFP, implicating that these 
mutated residues restored interaction with the mutant MFP (Nehme and Poole. 2007). 
 While a crystal structure is not available for OpmH, its structure, as well as OprM were 
modeled using an online modelling program, Phyre, visualized using UCSF Chimera v.1.5.2., 
and OpmH sequence was aligned to that of OprM using online multiple sequence alignment 
program ClustalW2 on the European Bioinformatics Institute website. The residues 
corresponding to OprM T198 and F439 in OpmH are E160 and Y412 respectively (Figure 13). 
As the corresponding residues have significantly different biochemical properties, it would be 
interesting to examine whether T198E and F439Y mutations in OprM, either independently or in 
tandem, has an effect on the effluxing capabilities of the MexJK-OprM complex. Particularly to 
see if substrate specificity would be altered from Erythromycin to Triclosan. Alternatively, the 
MexJK-OpmH complex effluxing capabilities can be examined with E160T and Y412F 
mutations in OpmH.  













Figure 13. Models of OprM and OpmH. OprM and OpmH were modeled using an online 
program, Phyre, with sequences retrieved from NCBI (Appendix 3). Residues of interest in 
OprM as previously determined and the corresponding residues in OpmH, as determined by 




























Further mutagenesis may be done on these mutants to isolate suppressors that alter the phenotype 
conferred by the proposed mutants T198E and F439Y in OprM, and E160T and Y412F in 
OpmH. It is likely that such suppressors map to the C-terminal domain of MexJ, as this region of 
the MFP has been characterized to mediate interaction with the OMP, and more specifically play 
a role in aperture opening (Weeks et al. 2010).  
 The novelty of the MexJK-OprM/OpmH RND efflux complex and its substrate 
specificity provides a good model with which to study and elucidate inter-component 
interactions between RND efflux pumps. Co-purification studies in the presence of various 
substrates will give insight into the native interactions between these proteins. Mutagenesis 
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APPENDIX A. Raw data from quantitative-real-time analysis of OpmH-H6 expression 
Target Sample Threshold Cycle 





rpsl PAO702/pET1.6P-opmH 18.70 18.79 0.129 
rpsl PAO702/pET1.6P-opmH 18.74 18.79 0.129 
rpsl PAO702/pET1.6P-opmH 18.94 18.79 0.129 
rpsl PAO702/pET1.6P-opmH + IPTG 18.32 18.48 0.196 
rpsl PAO702/pET1.6P-opmH + IPTG 18.41 18.48 0.196 
rpsl PAO702/pET1.6P-opmH + IPTG 18.70 18.48 0.196 
rpsl PA049 18.59 18.61 0.138 
rpsl PA049 18.48 18.61 0.138 
rpsl PA049 18.75 18.61 0.138 
rpsl PA049 + IPTG 17.94 18.14 0.190 
rpsl PA049 + IPTG 18.32 18.14 0.190 
rpsl PA049 + IPTG 18.16 18.14 0.190 
rpsl NTC 30.12 30.12 0.000 
rpsl NTC 30.15 30.15 0.000 
opmH PAO702/pET1.6P-opmH 22.67 22.91 0.330 
opmH PAO702/pET1.6P-opmH 23.14 22.91 0.330 
opmH PAO702/pET1.6P-opmH + IPTG 16.01 15.86 0.128 
opmH PAO702/pET1.6P-opmH + IPTG 15.77 15.86 0.128 
opmH PAO702/pET1.6P-opmH + IPTG 15.81 15.86 0.128 
opmH NTC  0.00 0.000 
opmH NTC 34.17 34.17 0.000 
opmH PA049 23.85 23.85 0.228 
opmH PA049 23.62 23.85 0.228 
opmH PA049 24.07 23.85 0.228 
opmH PA049 + IPTG 18.91 19.03 0.125 
opmH PA049 + IPTG 19.03 19.03 0.125 














APPENDIX B. Broth dilution MICs of Triclosan for P. aeruginosa PAO702 constructs 









Fold change in 
MIC compared to 
PAO702  
-IPTG  +IPTG  -IPTG  +IPTG  
PAO702  MexJ, MexK  0 1 1 0 0 










Multiple 1 1 0 0 
PA051  MexJ, MexK  0 1 1 0 0 
PA049  MexJ, MexK, 
OpmH  


























































APPENDIX D. Multiple sequence alignment of OpmH with OprM 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
OprM            MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREF 
60 
OpmH            ----------------------MLRRLSLAAAVAAATGVAWAAQP------------TPL 
26 
                                        :* . ..*.* . * *:. :.              : 
 
OprM            FRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDL 
120 
OpmH            PTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDE 
86 
                  ..:* .:   *::** ** .*  :  * :      **.*:*::*...     *:. *  
 
OprM            STTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVAT 
180 
OpmH            RPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFS----ATQQDLILRSAE 
142 
                 .:     *.   .**. . :. * : : :: :: : :  *  .    ::*  *:   *  
 
OprM            AYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQY 
240 
OpmH            TYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIA 
202 
                :*:*:   * :*  :*   .::::.:* ::. :***::.  *: :**:: : ***.     
 
OprM            TRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVP---AGLPSDLLQRRPDILEAEH 
297 
OpmH            EQRVDDAFQALVTLTNRDYSA--IEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNY 
260 
                 : * :  :*** * . . .*   :*:    .::. .*    .  .  :*:.  :* ::: 
 
OprM            QLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGS------GSWLFQP----SI 
347 
OpmH            AVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLEL 
320 
                 : **: ::   :*..:*::. .*:  . ..:  *: ::.:      *.:: :     .: 
 
OprM            NLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLV 
407 
OpmH            NIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAI 
380 
                *:**::.*   :.:  :  : : .  . *   : ..*:. :   * .* .**:**:*: : 
 
OprM            KASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGW 
467 
OpmH            ISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLS 
440 
                 :.:.  : ::  *:.*. * : :*:***.*::* ::  ..* : : . :.* :* *    
 
OprM            NQQTVTQQQTAKKE-DPQA----------------------- 485 
OpmH            PADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY 482 
                  :  : .   *:: **:                       
